INTRODUCTION
============

Silent brain infarctions (SBIs) are very common in the elderly ([@b1-cln_68p365]). SBIs are believed to be caused by the occlusion of small vessels and are therefore categorized as a small vessel disease (SVD); SVDs are related to different types of arteriole degeneration ([@b2-cln_68p365],[@b3-cln_68p365]). SBIs are mainly identified by imaging tools ([@b4-cln_68p365]) and are difficult to distinguish from old symptomatic lacunar infarctions (SLIs), which are also caused by the occlusion of small vessels and are usually regarded as SVDs ([@b2-cln_68p365]). Except for the different signals on diffusion-weighted images (DWIs) during the acute phase of SLIs, the lack of stroke-like symptoms or 'silence\' is the only prominent feature used to distinguish SBIs from SLIs ([@b1-cln_68p365],[@b4-cln_68p365]).

However, the 'silence\' of SBIs is still confusing to researchers and clinicians. The relatively small sizes of SBIs are the only widely accepted explanation for this peculiar feature ([@b1-cln_68p365],[@b5-cln_68p365]). However, SLIs that result in obvious symptoms can also be small. Several recent studies on the evolution of SLIs indicate that their final sizes are much smaller than those measured for DWIs after the onset of stroke ([@b6-cln_68p365]-[@b8-cln_68p365]). Thus, the difference between the sizes of SBIs and SLIs may require further evaluation. The size-related explanation for the 'silence\' of SBIs is also worth investigating.

Previous studies on lacunar infarcts mostly investigated the difference between SLI patients with or without SBIs ([@b5-cln_68p365],[@b9-cln_68p365],[@b10-cln_68p365]); few studies focused on the 'silence\' of SBIs. Furthermore, no study has compared the evolution of SBIs and SLIs. In this study, four groups were designed according to the presence of SBIs and SLIs. Vertical and horizontal comparisons of the following characteristics were performed among groups: risk factors, locations, evolution of infarctions, leukoaraiosis, atherosclerosis (AS) of relevant vessels, and the NIH Stroke Scale (NIHSS) scores of patients with SLIs. Based on the comparisons, we determined the possible mechanisms responsible for the 'silence\' of SBIs.

MATERIALS AND METHODS
=====================

General population of patients
------------------------------

This study was based on patients diagnosed with acute lacunar infarction or patients confirmed to have no signs of stroke who consecutively visited the Department of Neurology of the 10^th^ People\'s Hospital in Shanghai from December 2011 to August 2012. The patients had neurologic deficits, nonspecific symptoms (such as headaches), and dizziness; alternatively, they had a fear of stroke because of the presence of risk factors. The patients were administered a medical evaluation protocol, including brain magnetic resonance imaging (MRI), electrocardiogram, and blood tests for blood glucose, lipids, and homocysteine. All patients also underwent a vascular assessment involving either computed tomography angiography (CTA) or magnetic resonance angiography (MRA). Patients diagnosed with acute lacunar infarction were evaluated using the NIHSS. All procedures were approved by the Institutional Review Board of our hospital, and written informed consent was obtained from every participant.

Based on the presence of SBIs and SLIs on MRIs, 521 patients were enrolled and divided into four groups, namely, SBI, SLI, SBI&SLI (SS), and control groups. These groups consisted of the following patients: 156 patients with only SBIs, 90 patients with only new SLIs, 160 patients with both SBIs and new SLIs, and 115 patients without any identified infarcts. The following patients were excluded from these four groups: patients diagnosed with other types of stroke but not acute lacunar infarction, patients with a history of stroke, and patients with metallic implants.

In addition to the MRI results of the four groups listed above, two sets of images were analyzed retrospectively to study the evolution of SBIs and SLIs: 1) previous MR images of the 32 patients in the SBI and SS groups who underwent MRI more than once and 2) previous MR images obtained after the onset of stroke for the other 31 patients with lacunes identified as old SLIs.

MRI protocol
------------

The MR images in this study were primarily obtained using a 1.5 T scanner (Philips, Eindhoven, Noord-Brabant, Netherlands) and a 3.0 T scanner (Siemens, Erlangen, Bavaria, Germany). The MRI protocol consisted of a T1-weighted image \[repetition time/echo time (TR/TE) = 101/1.92 for the 1.5 T scanner and 2000/9 for the 3.0 T scanner\], fluid attenuated inversion recovery images (FLAIR) (TR/TE = 6000/110 for the 1.5 T scanner and 8500/94 for the 3.0 T scanner), DWI (TR/TE = 3393/86 for the 1.5 T scanner and 6000/94 for the 3.0 T scanner) in the axial plane, and a T2-weighted image (TR/TE = 1940/120 for the 1.5 T scanner and 4540/96 for the 3.0 T scanner) in the sagittal plane with 16 layers.

Review and criteria of the MR images
------------------------------------

All MR images were analyzed by two radiologists blinded to the clinical data. The discrepancies between the interpretations of the two readers regarding the presence of SBIs and SLIs and the leukoaraiosis scores were resolved by a visual consensus.

According to the conclusion on the evolution of acute lacunar infarctions, we defined SLI as a \<25-mm-diameter focal lesion that is hyper-intense on a DWI among small penetrating arteries distributed in the thalamus, gangliocapsular regions, corona radiata, and brainstem ([@b7-cln_68p365]). An SBI was defined as a \>3-mm-diameter focal cavitated lesion that is hypo-intense on T1-weighted images, hyper-intense on T2-weighted images, hypo-intense with a hyper-intense boundary on FLAIR images, and without corresponding stroke-like symptoms or neurologic deficits ([@b4-cln_68p365]). An old SLI was defined as a focal lesion with signals similar to an SBI on T1- and T2-weighted images, with signals similar to cavitations or leukoaraiosis on FLAIR, and with a corresponding history of stroke-like symptoms or neurologic deficits ([@b7-cln_68p365],[@b8-cln_68p365],[@b11-cln_68p365]). Old SLIs were analyzed only when the corresponding MR images after the onset of stroke were accessible at our workstation. The diameters of acute SLIs were measured on DWIs, T1-weighted images, and FLAIR images. The diameters of SBIs and old SLIs were measured on T1-weighted images and FLAIR images. All diameters listed for statistical analysis were the average of values measured by the two readers.

Leukoaraiosis was scored from 0 to 3 according to Fazekas\' scale ([@b12-cln_68p365]). Grades 2 to 3 leukoaraiosis were regarded as advanced leukoaraiosis (ad-LA).

Vascular risk factors and vascular assessment
---------------------------------------------

Data related to the following factors were collected: hypertension, diabetes mellitus (DM), dyslipidemia, ischemic heart disease (IHD), atrial fibrillation (AF), hyperhomocysteinemia (HHCY), smoking, and CTA or MRA results. Atherosclerotic plaques and stenosis of infarction-related arteries (e.g., middle cerebral and internal carotid arteries for infarctions in the gangliocapsular regions and basilar and vertebral arteries for infarctions in the brainstem) were considered to be possible atherosclerotic sources. AF diagnosed before or during hospitalization was regarded as a possible cardiogenic mechanism.

Statistical analyses
--------------------

All data were analyzed using SPSS (version 18.0, SPSS, Inc., Chicago, IL, USA). ANOVA and chi-squared tests were performed to compare the baseline characteristics and locations. The Student\'s t-test was used to compare infarction sizes and NIHSS scores. Multiple logistic regression models were constructed to determine the risk factors for SBIs and SLIs. *p*\<0.05 was considered to indicate a significant difference.

RESULTS
=======

Baseline characteristics of the four groups
-------------------------------------------

[Table 1](#t1-cln_68p365){ref-type="table"} lists the baseline characteristics of age, prevalence of different vascular risk factors, AS of relevant arteries, ad-LA, and the proportions of patients who underwent MRI on the 1.5 T scanner and CTA as the method of vascular assessment. Compared with the control group, the patients in the other three groups were relatively older and had higher prevalence rates of hypertension, HHCY, IHD, and ad-LA. The prevalence rates of DM, dyslipidemia, AF, and AS were also higher in the SLI group than in the control group.

Multiple comparisons among the SBI, SLI, and SS groups were also performed, and positive significant results (*p*\<0.05) are shown in [Table 2](#t2-cln_68p365){ref-type="table"}. Compared with the SLI group, patients in the SBI and SS groups were relatively older with higher prevalence rates of HHCY and ad-LA and lower prevalence rates of dyslipidemia and AS. No difference was observed for the prevalence of hypertension among the three groups. However, the durations of hypertension for hypertensive patients in the SBI and SS groups were significantly longer than for those in the SLI group (both *p*\<0.01). The NIHSS scores were higher in the SLI group than in the SS group (*p* = 0.017).

Risk factors of SBIs and SLIs *vs.* the control group
-----------------------------------------------------

Multiple regression models were constructed to identify the risk factors for different infarcts. The control group served as a reference, and the SS group was excluded. Sex, age, hypertension prevalence, DM, dyslipidemia, HHCY, IHD, AF, smoking, AS of relevant arteries, and ad-LA were added to the two models. The results are listed in [Table 3](#t3-cln_68p365){ref-type="table"}.

Locations of SBIs and SLIs
--------------------------

The locations of the SBIs and SLIs in the SBI, SLI, and SS groups were subsequently investigated, and the results are listed in [Table 4](#t4-cln_68p365){ref-type="table"}. Compared with SLIs, more SBIs were located in the corona radiata (*p*\<0.01) and fewer were located in the internal capsule and brainstem (*p*\<0.01 for both locations).

Size and evolution of infarcts
------------------------------

The diameters of the SBIs and SLIs were compared among groups and different time points. The average diameters of the SBIs and SLIs were determined based on all infarcts in the SBI, SLI, and SS groups. The comparisons among different time points were performed based on the MR images of 63 patients, i.e., 32 patients with 67 SBIs and 31 patients with 31 old SLIs obtained at different times. The results indicated that the sizes of the SBIs changed slightly after an average period of 13.4 months, whereas the SLIs shrank considerably after 13.0 months to final sizes nearly equal to those of the SBIs (*p* = 0.24). The details of this analysis are shown in [Table 5](#t5-cln_68p365){ref-type="table"}.

DISCUSSION
==========

This study revealed that the risk factors for the SBI and SLI groups differed to some extent and that the risk factors of the SS group were similar to those of the SBI group. The main risk factors for SBIs were hypertension, age, and HHCY; the main risk factors for SLIs were hypertension, DM, dyslipidemia, IHD, and AF. Patients with SBIs had long-term hypertension with a high prevalence of ad-LA, whereas the prevalence of AS in relevant arteries was much higher in the SLI and SS groups. Based on these different risk factors and features, the specific mechanisms of arterial occlusion can be speculated to differ between SBIs and SLIs. The classic mechanisms of SVDs, such as arteriolosclerosis caused by long-term hypertension, may be the main pathogenesis of SBIs. However, AS and embolisms are more important for SLIs ([@b5-cln_68p365],[@b10-cln_68p365],[@b13-cln_68p365],[@b14-cln_68p365]). The specific hypertension and leukoaraiosis-related pathogenesis of SBIs differs from the pathogenesis of SLIs and may be the main reason for the 'silence\' of SBIs.

Leukoaraiosis represents incomplete ischemia caused by the stenosis of small vessels. This condition progresses with age, and long-term hypertension that causes chronic arteriolosclerosis and arteriolar stenosis further aggravates the ischemia ([@b15-cln_68p365],[@b16-cln_68p365]). Furthermore, SBIs are commonly found to coexist with leukoaraiosis ([@b17-cln_68p365]). Thus, incomplete and chronic ischemia may also be the basis for SBIs. Prior to the appearance of SBIs, the particular region supplied by the arteriole with chronic arteriolosclerosis may be irreversibly and covertly impaired because of ischemia and may gradually lose its function. SBIs form after the threshold of ischemic stress is broken by the progress of ischemia. Thus, the 'silence\' of SBIs can be explained by chronic ischemic preconditioning and long-term ischemic tolerance. The comparison of the results between the SLI and SS groups in this study supports this explanation. The SS group consisted of significantly older patients than the SLI group, with longer hypertension durations but lower NIHSS scores. The lower NIHSS scores can be attributed to the neuroprotective effect of SBIs similar to the effects of previous transient ischemic attacks (TIA) ([@b18-cln_68p365]-[@b20-cln_68p365]). For both TIA and SBIs, ischemic preconditioning and ischemic tolerance may be the most reasonable explanations for this effect ([@b21-cln_68p365]-[@b23-cln_68p365]).

Another possible mechanism for the 'silence\' based on chronic ischemia is that the cavity of an SBI may gradually form within several days or even months with the progression of ischemia similar to the chronic progression of leukoaraiosis ([@b15-cln_68p365]) (i.e., no stroke-onset and neurologic symptoms). In fact, some SBIs are difficult to distinguish from focal leukoaraiosis. In our study on the evolution of infarctions, we observed that several SBIs tended to enlarge over time. However, this trend was not obvious and cannot be supported without frequent follow-up MRIs.

However, this study revealed that AS of relevant arteries was a strong risk factor for SLIs. In fact, Fisher and Caplan\'s pathological studies in the last century demonstrated that AS in perforating and parent arteries was an important cause for SLIs ([@b14-cln_68p365],[@b24-cln_68p365]). Some recent imaging studies also verified the association between SLIs and AS in parent and other relevant arteries ([@b25-cln_68p365]-[@b27-cln_68p365]). In addition, AS in parent arteries without obvious lumen stenosis and in perforating arteries could not be detected by most imaging tools; therefore, it might be underestimated as a common cause for SLIs ([@b27-cln_68p365]). Our results verified the association between SLIs and AS. However, IHD and AF were also identified as risk factors for single SLIs in this study. It has been suggested that single SLIs could also be caused by a cardiac embolism ([@b10-cln_68p365],[@b28-cln_68p365]). Therefore, the pathogenesis of some SLIs, particularly those without coexisting SBIs, might be different from the chronic and incomplete ischemic pattern of SBIs and instead may be similar to the pattern of large infarctions caused by acute and complete arterial occlusion due to AS or embolism. The benefit of thrombolytic therapy ([@b29-cln_68p365]) for SLI patients could also support this conclusion. In addition, most patients in the SLI group did not have leukoaraiosis or long-term hypertension. With a different pattern of arterial occlusion due to a different pathogenesis and without the pathological basis of chronic ischemia and neuroprotection of ischemic tolerance, these SLIs resulted in acute symptoms.

However, it is difficult to explain the overt symptoms of those SLIs without identified AS or with coexisting SBIs and leukoaraiosis. It is still possible that some of the SLIs might be related to acute and complete occlusion caused by undetectable AS of perforating arteries ([@b27-cln_68p365]). However, this hypothesis cannot be proven without pathological evidence. Meanwhile, it is not reasonable to attribute all of those SLIs to AS. The different locations can also be a possible reason for the 'silence\' and 'overtness\' of the infarcts. This study showed that more SBIs were identified in the corona radiata and basal ganglia; these locations were different from the distribution of SLIs. Compared with the internal capsule and brain stem, where more important conducting bundles and nuclei are concentrated, the corona radiata and basal ganglia are relatively nonstrategic areas, where small infarctions may cause only mild or even no symptoms.

This study also confirmed that the average final size of the SLIs was nearly equal to that of the SBIs. Therefore, the amount of brain tissue destroyed by the SLIs may be equal to the amount for the SBIs; consequently, the size-related explanation for the 'silence\' of SBIs might not be reasonable. The overestimation of the infarction size using DWIs may be caused by acute inflammation and edema, which exacerbate neurologic symptoms ([@b30-cln_68p365],[@b31-cln_68p365]). These pathological changes were also reported to be related to acute and complete ischemia ([@b31-cln_68p365]) and were not obvious in the pathogenesis of SBIs observed in the current study. Therefore, this difference between the evolution of SBIs and SLIs can also be attributed to the different patterns of ischemia and occlusion emphasized above.

In conclusion, this study showed that the 'silence\' of SBIs can be attributed to chronic ischemic preconditioning and long-term ischemic tolerance but not to the infarction size. The nonstrategic locations of these infarcts can also partly account for the 'silence\'. The strengths of this study included the consecutive study design with a relatively large sample size, multiple groups, and comparisons of different patterns. However, this study also had limitations. First, the study was not based on the general population, and the results may be influenced by the limited representativeness of the sample selected from hospitalized patients. Second, the study was based on clinical data and neuroimaging, and the results of the pathogenesis of SBIs and SLIs were speculated without confirmation by pathological examination. We cannot expound further on the pathogenesis, and more comprehensive studies are required.
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###### 

Baseline characteristics of the different groups.

                               SBI (*n* = 156)                                    SLI (*n* = 90)                                     SS (*n* = 160)                                     Control (*n* = 115)
  ---------------------------- -------------------------------------------------- -------------------------------------------------- -------------------------------------------------- ---------------------
  Female (%)                   50.6                                               51.1                                               48.1                                               55.7
  Age (years)                  68.9±7.0^b^                                        63.7±7.3^b^                                        70.7±7.0^b^                                        58.2±8.2
  Hypertension (%)             88.5^b^                                            80.0^b^                                            86.9^b^                                            31.3
  Diabetes (%)                 19.2                                               30.0^b^                                            21.3[a](#tfn1-cln_68p365){ref-type="table-fn"})    11.3
  Dyslipidemia (%)             64.1                                               78.9^b^                                            61.3                                               54.8
  Hyperhomocysteinemia (%)     69.2^b^                                            45.6 [a](#tfn1-cln_68p365){ref-type="table-fn"})   65.6^b^                                            30.4
  Ischemic heart disease (%)   14.1 [a](#tfn1-cln_68p365){ref-type="table-fn"})   16.7 [a](#tfn1-cln_68p365){ref-type="table-fn"})   13.8 [a](#tfn1-cln_68p365){ref-type="table-fn"})   5.2
  Atrial fibrillation (%)      7.7                                                12.2 [a](#tfn1-cln_68p365){ref-type="table-fn"})   8.1                                                3.5
  Current smoking (%)          25.0                                               30.0 [a](#tfn1-cln_68p365){ref-type="table-fn"})   35.0^b^                                            15.7
  Advanced leukoaraiosis (%)   53.8^b^                                            25.5^b^                                            60.1^b^                                            7.8
  Atherosclerosis (%)          14.7                                               47.8^b^                                            30.6^b^                                            5.2
  CTA (%)                      73.7                                               77.8                                               69.4                                               79.1
  1.5 T (%)                    72.4                                               74.4                                               76.3                                               73.9

*p*\<0.05, ^b^ *p*\<0.01 *vs.* the control group.

###### 

Positive results of the multiple comparisons.

  SBI group *vs.* SLI group                                           SBI group *vs.* SS group                                     SLI group *vs.* SS group
  ------------------------------------------------------------------- ------------------------------------------------------------ -------------------------------------------------------------------
  Age[b](#tfn2-cln_68p365){ref-type="table-fn"})                      Age                                                          Age[b](#tfn2-cln_68p365){ref-type="table-fn"})
  Diabetes                                                            Smoking                                                      Dyslipidemia[b](#tfn2-cln_68p365){ref-type="table-fn"})
  Dyslipidemia                                                        Atherosclerosis[b](#tfn2-cln_68p365){ref-type="table-fn"})   Hyperhomocysteinemia [b](#tfn2-cln_68p365){ref-type="table-fn"})
  Hyperhomocysteinemia [b](#tfn2-cln_68p365){ref-type="table-fn"})                                                                 Advanced leukoaraiosis[b](#tfn2-cln_68p365){ref-type="table-fn"})
  Advanced leukoaraiosis[b](#tfn2-cln_68p365){ref-type="table-fn"})                                                                Atherosclerosis[b](#tfn2-cln_68p365){ref-type="table-fn"})
  Atherosclerosis[b](#tfn2-cln_68p365){ref-type="table-fn"})                                                                       NIH Stroke Scale scores

*p*\<0.01.

###### 

Risk factors for SBI and SLI *vs.* the control group.

                           SBI *vs.* control       SLI *vs.* control                           
  ------------------------ ----------------------- ------------------- ----------------------- -------
  Sex                      0.723 (0.280-1.871)     0.504               1.019 (0.369-2.813)     0.970
  Age (years)              1.129 (1.024-1.245)     0.015               1.072 (0.977-1.177)     0.142
  Hypertension             21.708 (7.668-61.455)   0.000               6.320 (2.679-14.906)    0.000
  Diabetes                 0.959 (0.238-3.862)     0.953               3.654 (1.227-10.883)    0.020
  Dyslipidemia             1.869 (0.736-4.743)     0.188               3.535 (1.422-8.792)     0.007
  Hyperhomocysteinemia     8.331 (3.138-22.118)    0.000               1.699 (0.686-4.205)     0.252
  Ischemic heart disease   2.139 (0.448-10.222)    0.341               4.163 (1.105-15.691)    0.035
  Atrial fibrillation      2.509 (0.334-18.858)    0.372               7.262 (1.094-48.218)    0.040
  Smoking                  4.605 (1.154-18.380)    0.031               4.095 (1.258-13.328)    0.019
  Advanced leukoaraiosis   4.357 (1.978-9.598)     0.000               1.179 (0.522-2.664)     0.692
  Atherosclerosis          0.473 (0.101-2.220)     0.343               13.951 (4.628-42.057)   0.000

###### 

Locations of the SBIs and SLIs.

                     SBI (*n* = 702)   SLI (*n* = 250)
  ------------------ ----------------- -----------------
  Basal ganglia      176 (25.07%)      48 (19.2%)
  Thalamus           93 (13.25%)       25 (10.00%)
  Internal capsule   51 (7.26%)        60 (24.00%)^b^
  Corona radiata     308 (43.87%)      53 (21.20%)^b^
  Brainstem          74 (10.54%)       64 (25.60%)^b^

*p*\<0.05, ^b^ *p*\<0.01.

###### 

Size and evolution of the infarcts.

                                                   SBI        SLI
  ------------------------------------------------ ---------- -------------
  Average diameter on T1/FLAIR (mm)                7.9±2.8    13.9±4.3^b^
  Average diameter on a DWI (mm)                   --         14.2±5.0
  Previous diameter on T1/FLAIR (mm)^c^            8.0±2.3    14.0±3.9^b^
  Previous diameter on a DWI (mm)^c^               --         14.3±4.5
  Duration of two time points of MRI (months)^c^   13.4±3.5   13.0±3.3
  Follow-up diameter on T1/FLAIR (mm)^c^           8.1±2.3    8.7±2.7

*p*\<0.05, ^b^ *p*\<0.01, ^c^ based on 63 patients with MR images at two time points.
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